全球动脉粥状硬化斑块切除术设备市场规模（按类型、应用、最终用户、区域范围和预测）

动脉粥状硬化斑块切除术设备的市场规模与预测

预计 2024 年动脉粥状硬化斑块切除术设备市场规模将达到 16.3 亿美元，2031 年将达到 25.4 亿美元，2024 年至 2031 年的复合年增长率为 6.25%。

动脉粥状硬化斑块动脉粥状硬化斑块切除术器械是专门设计用于去除动脉壁斑块并改善动脉粥样硬化患者血流的医疗器械。这些器械透过切割、磨除或汽化导致动脉狭窄或阻塞的斑块来发挥作用，尤其适用于周边动脉疾病和冠状动脉疾病。动脉粥状硬化动脉粥状硬化斑块切除术通常为微创手术，并与其他治疗方法（例如血管成形术和斑块置入术）合併使用。动脉粥状硬化斑块动脉粥状硬化斑块切除术对于治疗钙化斑块或硬斑块非常有效，因为这些斑块单靠传统的球囊血管成形术难以处理。

由于心血管疾病盛行率上升、人口老化以及设备技术的进步，全球动脉粥状硬化斑块切除术设备市场预计将显着成长。影像和导航技术的新发展，以及对微创手术的需求，预计将推动该领域的创新。

新兴市场对动脉粥状硬化斑块切除术的日益普及、医疗基础设施的改善以及优惠的报销政策，预计将扩大这些设备的覆盖范围和可及性。更高的准确性、更佳的安全性以及与人工智慧诊断技术的整合，也是动脉粥状硬化斑块切除术设备未来发展的光明方向。

全球动脉动脉粥状硬化斑块切除术设备市场动态

影响全球动脉粥状硬化斑块切除术硬化斑块切除设备市场的关键市场动态是：

关键市场驱动因素

周边动脉疾病(PAD) 盛行率上升：PAD 发生率的上升是动脉粥状硬化斑块切除术器械市场的主要驱动力。根据美国美国650 万 40 岁及以上人口患有 PAD。 PAD 的盛行率随着年龄增长而上升，在 60 岁及以上人群中，PAD 的盛行率高达 12% 至 20%。患者群体的不断增长使得对动脉粥状硬化斑块切除器械等有效治疗方案的需求日益迫切。

微创手术的普及率不断提高：人们对微创治疗的偏好日益增长，推动了对斑块动脉粥状硬化斑块切除术器械的需求。血管外科学会报告称，过去十年，包括动脉粥状硬化斑块切除术在内的血管内手术增加了30%。这一趋势的动力源于微创技术带来的住院时间缩短、併发症减少以及恢復时间加快。

动脉粥状硬化斑块切除术设备的技术进步：动脉粥状硬化斑块动脉粥状硬化斑块切除术技术的持续创新正在推动市场发展。美国心臟协会报告称，与传统方法相比，药物涂层球囊血管成形术合併动脉粥状硬化斑块切除术硬化斑块切除术可将再血管再阻塞率降低50%。这种疗效的提升正推动先进动脉粥状动脉粥状硬化斑块切除术术设备在医院和门诊病人的普及。

主要挑战

设备和手术高成本：动脉粥状硬化斑块切除设备及相关手术价格昂贵，限制了低收入地区和无健保患者的普及。高昂的设备成本以及对熟练操作人员的需求，加重了医疗机构的财务负担。在某些地区，报销政策的不完善进一步加剧了这项挑战，使医院难以广泛采用这些设备。这些设备的成本效益较低，尤其是与血管成形术和置入术等替代治疗方法相比，这也阻碍了它们在成本敏感市场的广泛接受。

手术复杂性：由于斑块清除手术极为精细，尤其是在复杂或钙化动脉阻塞的情况下，动脉粥状硬化斑块切除术术需要医护人员具备高超的技能和丰富的经验。手术过程中的任何错误都可能导致动脉穿孔或斑块栓塞等併发症，给患者带来重大风险。这种复杂性使得许多医疗机构，尤其是开发中地区的医疗机构，不愿意采用这种手术。

报销政策有限：在许多国家，切除术的保险报销框架不如血管成形术等传统治疗的保险报销框架全面。这种覆盖范围的缺失给医疗服务提供者和患者都带来了经济负担。即使有报销，也可能无法覆盖手术的全部费用，从而阻碍了医院投资必要的设备。报销政策的地区差异，也给寻求在多个国家销售动脉粥状硬化斑块切除术硬化斑块切除术设备的全球製造商带来了额外的挑战。

主要趋势：

即时分析需求日益增长：随着决策越来越依赖即时数据，记忆体内变得至关重要。这些资料库透过将资料直接储存在RAM中，实现了超高速资料搜寻和处理，无需使用速度较慢的磁碟储存。金融、电子商务和通讯等行业需要即时分析来做出即时决策并提高营运效率。对即时资料处理日益增长的需求预计将推动对记忆体内的需求，尤其是在高频交易、诈欺侦测和个人化客户体验领域。

记忆体内运算在巨量资料中的应用：巨量资料的快速成长推动了记忆体内运算(IMC) 的广泛应用。传统的基于磁碟的资料库难以即时处理和分析海量资料集，而记忆体内能够快速存取和分析海量资料。记忆体资料库 (IMDB) 显着降低了巨量资料分析的延迟，从而更快获得洞察，帮助企业做出更明智的决策。这在医疗保健、零售和物联网等行业尤其重要，这些行业需要快速处理大量数据以获得切实可行的洞察。

云端基础的记忆体内使用率不断增长：随着企业将其资料基础设施迁移到云端环境，云端技术的采用正在推动记忆体内资料库市场的成长。与本地解决方案相比，云端基础的记忆体内具有更高的扩充性、灵活性和成本效益。它们还能实现更快的资源配置和按需资源扩展，这对于工作负载波动的企业至关重要。向云端运算的转变正在推动企业采用记忆体内，以更灵活、更经济的方式充分利用高速资料处理的优势。

动脉粥状硬化斑块切除术切除设备全球市场概况

骨肿瘤和骨髓炎等整形外科疾病的发生率上升正在推动市场扩张。动脉粥状硬化斑块切除术器械最常见的用途是治疗持续性骨髓炎。运动伤害和其他创伤、骨折和骨骼病变的增加预计将在未来刺激市场扩张。冠状动脉疾病 (CAD) 和周边动脉疾病(PAD) 盛行率的上升预计将推动动脉粥状硬化斑块切除术器械市场的发展。动脉粥状硬化斑块切除术器械在周边动脉疾病(PAD) 的诊断和治疗中发挥重要作用。

与传统治疗方法相比，该设备具有许多优势，例如併发症风险更低、手术舒适度更高。雷射动脉粥状硬化斑块切除术设备的快速普及预计将推动市场成长。与机械系统相比，该设备也具有许多优势，例如功能更丰富、效率更高，且无需使用栓塞保护装置。

此外，雷射植入式动脉粥状动脉粥状硬化斑块切除术术设备可以清除血栓、溶解促凝血反应物，并在不损伤周围组织的情况下切除底层斑块。因此，预计未来几年雷射动脉粥状动脉粥状硬化斑块切除术设备的使用将推动市场发展。未来几年，对技术发展的日益重视预计将推动市场发展。

此外，支持医疗基础设施快速扩张的强劲研究很可能在整个预测期内推动市场成长。低度开发国家的人们对易于获取的疾病诊断和治疗方法的了解有限，预计这将在未来几年限制市场成长。此外，训练有素的外科医生短缺预计将在预测期内抑制市场成长。

目录

第一章全球动脉粥状硬化斑块切除术切除设备市场简介

• 市场概况
• 调查范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球动脉粥状硬化斑块切除术设备市场展望

• 概述
• 市场动态
  • 驱动程式
  • 抑制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球动脉粥状硬化斑块切除术设备市场（依产品）

• 概述
• 定向旋磨系统
• 眼眶动脉粥状动脉粥状硬化斑块切除术系统
• 光消融（雷射）动脉粥状硬化斑块切除术系统
• 旋动脉粥状硬化斑块切除术系统

第六章全球动脉粥状硬化斑块切除术切除设备市场（依应用）

• 概述
• 週边血管
• 心血管
• 神经血管

第七章全球动脉粥状硬化斑块切除术切除设备市场（依最终用户）

• 概述
• 医院和外科中心
• 研究机构和学术机构
• 门诊医疗中心
• 其他的

第八章全球动脉粥状硬化斑块切除术设备市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第九章全球动脉粥状硬化斑块切除术斑块切除设备市场的竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第十章：公司简介

• Boston Scientific Corporation
• Abott Laboratories
• Cardiovascular Systems Inc.
• BARD Peripheral Vascular
• Medtronic
• Straub Medical AG
• Cardinal Health
• Volcano Corporation

第十一章 重大进展

• 产品发布/开发
• 併购
• 业务扩展
• 伙伴关係和联盟

第十二章 附录

• 相关调查

Atherectomy Devices Market Size And Forecast

Atherectomy Devices Market size was valued at USD 1.63 Billion in 2024 and is projected to reach USD 2.54 Billion by 2031, growing at a CAGR of 6.25% from 2024 to 2031.

Atherectomy devices are specialized medical instruments designed to remove plaque from the walls of arteries, improving blood flow in patients suffering from atherosclerosis. These devices work by cutting, grinding, or vaporizing arterial plaque that narrows or blocks the arteries, particularly in peripheral or coronary artery disease. Atherectomy procedures are often minimally invasive and are used in combination with other interventions such as angioplasty or stenting. They are highly valuable for treating calcified or hard plaque that is difficult to manage with conventional balloon angioplasty alone.

The global market for atherectomy devices is expected to grow significantly due to rising cardiovascular disease prevalence, an aging population, and advancements in device technology. New developments in imaging and navigation technologies, along with the demand for less invasive procedures, are expected to drive innovation in this field.

The increasing adoption of atherectomy procedures in emerging markets, improved healthcare infrastructure, and favorable reimbursement policies are likely to expand the scope and accessibility of these devices. Enhanced precision, better safety profiles, and integration with AI-powered diagnostics are also promising directions for the future of atherectomy devices.

Global Atherectomy Devices Market Dynamics

The key market dynamics that are shaping the global atherectomy devices market include:

Key Market Drivers:

Rising Prevalence of Peripheral Artery Disease (PAD): The increasing incidence of PAD is a major driver for the atherectomy devices market. According to the Centers for Disease Control and Prevention (CDC), approximately 6.5 million people aged 40 and older in the United States have PAD. The prevalence of PAD increases with age, affecting 12-20% of individuals over 60 years old. This growing patient population necessitates effective treatment options like atherectomy devices.

Increasing Adoption of Minimally Invasive Procedures: There's a growing preference for minimally invasive treatments, which is boosting the demand for atherectomy devices. The Society for Vascular Surgery reports that endovascular procedures, including atherectomy, have increased by 30% over the past decade. This trend is driven by shorter hospital stays, reduced complications, and faster recovery times associated with minimally invasive techniques.

Technological Advancements in Atherectomy Devices: Ongoing innovations in atherectomy technology are expanding the market. According to a report by the American Heart Association, the use of drug-coated balloon angioplasty in conjunction with atherectomy has shown a 50% reduction in restenosis rates compared to traditional methods. This improved efficacy is driving the adoption of advanced atherectomy devices in both hospitals and outpatient settings.

Key Challenges:

High Cost of Devices and Procedures: Atherectomy devices and the associated procedures are expensive, limiting their accessibility in low-income regions and for uninsured patients. High equipment costs, along with the need for highly skilled operators, increase the financial burden on healthcare providers. In some regions, inadequate reimbursement policies further add to the challenges, making it difficult for hospitals to adopt these devices widely. The lack of cost-effectiveness, especially when compared to alternative treatment methods like angioplasty or stenting, hampers their broader acceptance in cost-sensitive markets.

Complexity of Procedures: Atherectomy procedures require a high level of skill and experience from healthcare professionals, particularly due to the delicate nature of plaque removal in complex or calcified arterial blockages. Any error during the procedure can lead to complications, such as arterial perforation or plaque embolization, posing a significant risk to the patient. This complexity deters many healthcare facilities, especially in developing regions, from adopting the procedure.

Limited Reimbursement Policies: In many countries, the reimbursement framework for atherectomy procedures is not as comprehensive as it is for more traditional treatments like angioplasty. This lack of coverage creates financial strain on both healthcare providers and patients. Where reimbursement does exist, it may not cover the entire cost of the procedure, creating hesitancy in hospitals to invest in the necessary equipment. Varying reimbursement policies across different regions adds complexity for global manufacturers looking to market atherectomy devices in multiple countries.

Key Trends:

Growing Demand for Real-Time Analytics: With businesses increasingly relying on real-time data for decision-making, in-memory databases are becoming essential. These databases offer ultra-fast data retrieval and processing by storing data directly in RAM, eliminating the need for slower disk-based storage. Industries like finance, e-commerce, and telecom require real-time analytics to make split-second decisions, enhancing operational efficiency. As the need for instantaneous data processing grows, the demand for in-memory databases is expected to rise, especially in high-frequency trading, fraud detection, and personalized customer experiences.

Adoption of In-Memory Computing for Big Data: The proliferation of big data has led to the widespread adoption of in-memory computing (IMC). Traditional disk-based databases struggle to process and analyze massive datasets in real-time, while in-memory databases offer high-speed access and analysis, even with large volumes of data. IMDBs significantly reduce latency in big data analytics, providing faster insights for better decision-making. This is particularly important in industries like healthcare, retail, and IoT, where vast amounts of data need to be processed quickly to gain actionable insights.

Rising Use of Cloud-Based In-Memory Databases: Cloud adoption is accelerating the growth of the in-memory database market as businesses move their data infrastructure to cloud environments. Cloud-based in-memory databases offer scalability, flexibility, and cost-efficiency compared to on-premises solutions. They also provide faster provisioning and the ability to scale resources on demand, which is crucial for businesses with fluctuating workloads. The shift to cloud computing is driving organizations to adopt in-memory databases to take advantage of high-speed data processing in a more flexible and cost-effective manner.

Global Atherectomy Devices Market Overview

The increased occurrence of orthopedic illnesses such as bone tumors and osteomyelitis is driving market expansion. The most prevalent application of atherectomy devices is to treat persistent osteomyelitis. The increase in sports injuries and other types of trauma, bone fractures, and bone lesions is projected to fuel market expansion in the future. The increasing prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD) is likely to drive the Atherectomy Devices market. Atherectomy devices play a significant role in the diagnosis and treatment of peripheral artery disease (PAD).

When compared to traditional therapies, the devices provide various advantages, including a lower risk of problems and a higher degree of comfort during surgery. The rapidly increasing usage of Laser Atherectomy Devices is expected to fuel market growth. When compared to mechanical systems, these systems provide various advantages, including more versatility, increased efficiency, and the removal of the requirement for embolic protective devices.

Furthermore, laser-embedded atherectomy devices can remove thrombi, dissolve procoagulant reactants, and debulk the underlying plaque without causing damage to the surrounding tissue. As a result, the increased use of laser atherectomy devices is projected to boost the market in the coming years. The growing emphasis on technology developments is expected to boost the market in the coming years.

In addition, substantial research supporting the fast expansion of medical infrastructure is likely to boost market growth throughout the forecast period. People in underdeveloped nations have limited knowledge of the ease with which disease diagnostics and treatments are available, which is predicted to limit market growth in the coming years. Furthermore, a shortage of trained surgeons is projected to constrain market growth during the forecasted period.

Global Atherectomy Devices Market Regional Analysis

Here is a more detailed regional analysis of the global atherectomy devices market:

North America:

North America leads the global atherectomy devices market due to a high prevalence of cardiovascular diseases, especially peripheral artery disease (PAD). In the United States alone, around 8.5 million people are affected by PAD, with 12-20% of individuals over the age of 60 suffering from the condition, as reported by the CDC. As cardiovascular disease rates continue to rise, with the American Heart Association projecting that 43.9% of the U.S. population will be affected by 2030, the demand for advanced treatment options like atherectomy devices is growing. The region's healthcare systems are well-equipped to handle this demand, and the increasing burden of cardiovascular disease is a key driver behind the market's growth.

North America's strong healthcare infrastructure and rapid adoption of advanced medical technologies are major factors supporting market dominance. The number of endovascular procedures, including atherectomy, has surged by 40% over the past five years, driven by technological advancements and improved patient outcomes. Favorable reimbursement policies are also fueling this growth. Medicare has increased atherectomy reimbursement rates by 15% since 2020, and projections suggest a 7% annual rise in reimbursement for minimally invasive vascular procedures over the next three years.

Asia Pacific:

The Asia Pacific region is experiencing rapid growth in the atherectomy devices market, driven primarily by the rising prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD). According to the World Health Organization (WHO), cardiovascular diseases account for 31% of all deaths in the Western Pacific region, and this figure is expected to rise. The Asia Pacific Society of Cardiology reports a 28% increase in PAD cases over the past decade, with 54 million people affected in 2020, projected to reach 70 million by 2030. The region's aging population further amplifies this trend, as the United Nations predicts that by 2050, one in four people in Asia Pacific will be over the age of 60. This demographic shift is contributing to a growing demand for advanced cardiovascular treatments like atherectomy devices.

The region's improving healthcare infrastructure and increasing healthcare expenditure are key factors driving market growth. Healthcare spending in Asia Pacific has been growing at an average annual rate of 6.5% since 2015, surpassing global averages. This trend is expected to accelerate, with an 8% annual increase projected over the next five years, enabling the adoption of advanced medical technologies such as atherectomy devices.

The rising awareness of minimally invasive procedures has fueled the demand for atherectomy devices. A significant increase in minimally invasive vascular procedures, particularly atherectomy, has been observed across major Asian countries, with a 45% growth between 2018 and 2022. This trend is forecasted to continue, with a projected 60% rise in atherectomy procedures by 2028, further driving the market in the Asia Pacific region.

Global Atherectomy Devices Market: Segmentation Analysis

The Global Atherectomy Devices Market is Segmented on the basis of Type, Application, End User, And Geography.

Atherectomy Devices Market, By Type

Rotational Atherectomy Devices

Directional Atherectomy Devices

Based on Type, the market is fragmented Rotational Atherectomy Devices, Directional, and Atherectomy Devices. Rotational atherectomy devices are currently dominating due to their effectiveness in treating calcified lesions, which are often challenging to manage with other techniques. These devices utilize a rotating diamond-coated burr to remove plaque from arterial walls, making them particularly valuable in complex cases and contributing to their widespread adoption among healthcare providers. Directional atherectomy devices are rapidly growing in popularity, driven by their ability to selectively remove atheromatous material while preserving healthy vascular tissue. As the demand for less invasive and more precise treatment options increases, the directional atherectomy segment is expected to expand significantly, appealing to both physicians and patients seeking optimal outcomes with minimal complications.

Atherectomy Devices Market, By Application

Cardiovascular Applications

Peripheral Vascular Applications

Based on Application, the market is divided into Cardiovascular Applications and peripheral Vascular Applications. Cardiovascular applications dominate due to the high prevalence of coronary artery disease and the need for effective plaque removal techniques in managing complex cardiovascular conditions. These applications are critical as they address the urgent need for advanced treatment options, leading to increased adoption of atherectomy devices in hospitals and surgical centers. Peripheral vascular applications are rapidly growing, driven by the rising incidence of peripheral artery disease (PAD), especially among aging populations. As awareness of PAD and its associated risks increases, there is a greater demand for specialized treatments, including atherectomy procedures, to improve blood flow and alleviate symptoms, positioning this segment for significant growth in the coming years.

Atherectomy Devices Market, By End User

Ambulatory Surgical Centers (ASCs

Hospitals

Based on End User, the market is segmented into Ambulatory Surgical Centers (ASCs) and hospitals. Hospitals dominate as the primary end users due to their advanced surgical capabilities, comprehensive healthcare services, and access to specialized personnel for complex procedures. Hospitals typically handle a larger volume of patients requiring atherectomy procedures, particularly for severe cases of cardiovascular diseases, making them crucial players in this market. Ambulatory Surgical Centers (ASCs) are experiencing rapid growth, driven by the increasing trend toward outpatient procedures and the demand for minimally invasive surgeries. ASCs offer cost-effective and efficient alternatives to traditional hospital settings, attracting patients who prefer quicker recovery times and lower hospital stay durations, thus contributing significantly to the expansion of the atherectomy devices market.

Atherectomy Devices Market, By Geography

North America

Asia Pacific

Europe

Rest of the world

On the basis of geographical analysis, the atherectomy devices market is classified into North America, Asia Pacific, Europe, and Rest of the world. North America dominates the global atherectomy devices market, driven by the high prevalence of cardiovascular diseases like peripheral artery disease (PAD), well-established healthcare infrastructure, and favorable reimbursement policies. The Asia Pacific region is rapidly growing due to the increasing incidence of cardiovascular diseases, an aging population, improving healthcare infrastructure, and rising healthcare expenditures.

Key Players

The "Global Atherectomy Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Boston Scientific Corporation, Philips, Cardiovascular Systems Inc., Avinger Inc., Terumo Corporation, B. Braun Melsungen AG, Abbott Laboratories, Ra Medical Systems, and AngioDynamics.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Atherectomy Devices Market Recent developments
• In August 2022, AngioDynamics, Inc. announced that the Auryon Atherectomy System has gained 510(k) clearance for an expanded indication that includes arterial thrombectomy.
• In February 2022, RA Medical Systems announced that enrollment has reached 95 subjects in the pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ATHERECTOMY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ATHERECTOMY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Directional Atherectomy Systems
• 5.3 Orbital Atherectomy Systems
• 5.4 Photo-Ablative (Laser) Atherectomy Systems
• 5.5 Rotational Atherectomy Systems

6 GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Peripheral Vascular
• 6.3 Cardiovascular
• 6.4 Neurovascular

7 GLOBAL ATHERECTOMY DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals & Surgical Centers
• 7.3 Research Laboratories & Academic Institutes
• 7.4 Ambulatory Care Centers
• 7.5 Others

8 GLOBAL ATHERECTOMY DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL ATHERECTOMY DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Boston Scientific Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Abott Laboratories
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Cardiovascular Systems Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 BARD Peripheral Vascular
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Medtronic
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Straub Medical AG
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Cardinal Health
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Volcano Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research